Notice & Comment

Author: Nicholas Bagley

Notice & Comment

Why the federal government must take the lead on reform.

In yesterday’s post on my new draft essay, Federalism and the End of Obamacare, I emphasized the benefits of returning more regulatory authority to the states. Today, I’d like to draw out a different point: the need for the federal government to take the lead when it comes to financing health reform. The states face […]

Notice & Comment

Federalism and the End of Obamacare

That’s the title of my new essay, which the Yale Law Journal Forum has published in draft form. Here’s the abstract. Federalism has become a watchword in the acrimonious debate over a possible replacement for the Affordable Care Act (ACA). Missing from that debate, however, is a theoretically grounded and empirically informed understanding of how […]

Notice & Comment

A congressional inquiry into orphan drugs

In response to a scathing report by Kaiser Health News, Senator Charles Grassley has announced an inquiry into the exorbitant prices for orphan drugs. Now seems like a good time to highlight my series, published at The Incidental Economist, on how to think straight about orphan drugs: Background on orphan drugs and the Orphan Drug […]

Notice & Comment

Is 3.49 more than 3?

Apparently Trump’s HHS doesn’t think so. From Jonathan Cohn at the Huffington Post: HHS has already submitted a proposal of new rules to OMB. [Under the proposal,] insurers would have more leeway to vary prices by age, so that premiums for the oldest customers could be 3.49 times as large as those for younger customers. […]

Notice & Comment

When norms break down.

I’ve got an article up at Vox on the possibility that Donald Trump might suspend enforcement of the ACA’s individual mandate. Would that be legal? The short answer is no. The longer answer is more complicated, but it’s also instructive. At key points, President Barack Obama delayed aspects of the ACA in an effort to […]

Notice & Comment

Executive actions Trump could take to change the ACA

This post was coauthored by Nicholas Bagley and Adrianna McIntyre.  The executive order President Trump signed on Friday does not have any immediate policy effect, but it does call attention to the wide range of administrative actions that a Trump administration could take to change the Affordable Care Act—all without legislation from Congress. We’ve compiled […]

Notice & Comment

The Trump Executive Order on the ACA

There are some misconceptions floating around about what the executive order does and doesn’t do. Let me try to clarify. As I explained in a post last week, “[a]uthority to implement the ACA … is vested in the Secretaries of HHS, Treasury, and Labor—not the President. In the context of the ACA, an executive order […]

Notice & Comment

How to Avoid a Post-Antibiotic World

Kevin Outterson and I have an op-ed in the New York Times today on combating antimicrobial resistance. Here’s a snippet: [W]e will miss antibiotics when they’re gone. Minor scrapes and routine infections could become life threatening. Common surgeries would start looking like Russian roulette. Gonorrhea and other sexually transmitted infections might become untreatable. Diseases that […]

Notice & Comment

Restoring access to federal health-care data.

Three years ago, and without notice, data about patients with substance use disorders began to disappear from Medicare and Medicaid files widely used in health services research. Because researchers had been afforded access to those data for decades, the change was mystifying. Austin Frakt raised an alarm, and he and I began to look into […]

Notice & Comment

Trump’s “executive orders” are a communications strategy.

According to Vice-President-elect Pence, “We’re working now on a series of executive orders that will enable that orderly transition to take place even as Congress appropriately debates alternatives to and replacements for ObamaCare.” This talk about using executive orders to assure an “orderly transition” is a bit confusing. An E.O. has legal force “only if […]

Notice & Comment

Screwing Congress

There’s been a lot of talk about the executive actions that President Trump might take to reshape the Affordable Care Act. Here’s one I haven’t heard discussed: undoing the Hill fix. Prior to the ACA, members of Congress and their staffers got health coverage through their jobs, just like most Americans. But Congress wanted to […]

Notice & Comment

A step forward on surprise billing.

Per a rule released last week, CMS will now require qualified health plans to count the cost sharing paid by the enrollee for an essential health benefit provided by an out-of-network ancillary provider at an in-network setting towards the enrollee’s in-network annual limitation on cost sharing for QHPs in certain circumstances. Let’s say you go […]

Notice & Comment

Patching the ACA at the state level.

When it comes to repealing the ACA, one of the trickiest questions concerns timing. Congressional Republicans don’t want to pitch 20 million people off of their insurance right away. Nor do they want the midterm elections to be fought amidst the collapse of the individual market. At the same time, they’re committed to repeal. To […]

Notice & Comment

Boom goes the ACA?

Republicans may have the votes pass a reconciliation bill that will hollow out the ACA in a few years. They pinkie swear that, at that point, they’ll pass some kind of replacement. But for that to work, they’ll need Democratic support. Chuck Schumer is already saying they won’t get it: “We’re not going to do […]